{"title":"Current Glycomics' Approaches: Subprojects and Journals","authors":"V. Pomin","doi":"10.4172/2153-0637.1000E102","DOIUrl":null,"url":null,"abstract":"After the era of genome, proteome, metabolome, and lipidome, the age of glycome has launched in biology bringing so far more challenges than the first “ome” projects. The long major conception of carbohydrates as just energetically involved class of biomolecules (basically until early 80’s) has fallen apart as innumerable other essential biological roles have been documented. The current glycomics’ boom [1] has been proving the importance of this class of molecules in many fields regarding the sciences of chemistry and biology. And nowadays the amount of data concerning biological actions of carbohydrates is very high which turned out to be impossible to enlist all types of action together at once. Such actions involve not only essential roles in cell [2] like growth, migration, differentiation or signaling events, or in physiology [2] like immunology, hematology, and histology, but within a different context, carbohydrates can also exhibit potent biomedical applications as anticoagulant, antithrombotic, anti-inflammatory, antivirotic, antipathogenic, antitumorigenic, antimetastatic, antiangiogenic agents, among other therapeutic uses [3,4].","PeriodicalId":89585,"journal":{"name":"Journal of glycomics & lipidomics","volume":"2 1","pages":"1-4"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of glycomics & lipidomics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2153-0637.1000E102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
After the era of genome, proteome, metabolome, and lipidome, the age of glycome has launched in biology bringing so far more challenges than the first “ome” projects. The long major conception of carbohydrates as just energetically involved class of biomolecules (basically until early 80’s) has fallen apart as innumerable other essential biological roles have been documented. The current glycomics’ boom [1] has been proving the importance of this class of molecules in many fields regarding the sciences of chemistry and biology. And nowadays the amount of data concerning biological actions of carbohydrates is very high which turned out to be impossible to enlist all types of action together at once. Such actions involve not only essential roles in cell [2] like growth, migration, differentiation or signaling events, or in physiology [2] like immunology, hematology, and histology, but within a different context, carbohydrates can also exhibit potent biomedical applications as anticoagulant, antithrombotic, anti-inflammatory, antivirotic, antipathogenic, antitumorigenic, antimetastatic, antiangiogenic agents, among other therapeutic uses [3,4].